Thursday, October 15, 2026
The Federal Reserve Bank of Philadelphia said on Thursday 15 October that its manufacturing index fell to 20.9 from 37.8, the second monthly decline, though it remains positive. New orders fell to 4.3 from 29.2. The prices-received index rose to 40.1, its highest since May 2025.
The Federal Reserve Bank of New York said on Thursday 15 October that its Empire State Manufacturing Survey general business conditions index rose 18 points to 25.5 in October, the highest since December 2021. New orders rose 21 points to 23.2, while the employment index held at 10.3, pointing to modest hiring, and supply availability fell to its lowest since June 2022.
Thirty-six percent of OEM manufacturers had reshored or were actively reshoring in 2026, up from twenty-nine percent in 2025, according to the Reshoring Initiative's second annual survey. The constraint is not capital. Sixty-six percent of respondents rated hiring skilled technicians as very difficult or at crisis levels.
TSMC's Arizona Fab 21 is producing 4-nanometer chips at 24,000 wafers per month. Intel's Ohio campus has shipped revenue wafers. Samsung's Texas facility is running. Combined, the three facilities represent roughly 8 percent of global advanced-node capacity. The gap between what is producing and what the full domestic supply chain requires is measured in years.
Teikoku Databank counted 10,118 Japanese companies with a presence in mainland China in June, down 22 per cent in two years and 30 per cent from the 2012 peak. A record 4,137 left or could no longer be traced. Among those that remain, China's standing as a production base has slipped only a little since 2019. Its standing as a market has collapsed.
International Motors, formerly Navistar, stopped building trucks in Springfield, Ohio, on Wednesday and laid off the 1,341 people on its state notice. The plant's main work, assembling Chevrolet Silverado medium-duty trucks for General Motors, ended with the contract. The buyer, Canada's Roshel, says it plans to more than double the workforce over time. The city says it has not been told when.
Spending on data center construction reached a seasonally adjusted annual rate of $85 billion in August, the Census Bureau said, up 73 per cent in a year. Spending on computer, electronics and electrical factories, the category that includes chip plants, has fallen to $52 billion from $126 billion in mid-2024. Without data centers, private nonresidential construction is down about 6 per cent on a year ago.
Caterpillar said on Wednesday it will invest about $1 billion in a new plant in Sanford, North Carolina, to build more compact track loaders and telehandlers. Lee County and the City of Sanford have approved up to $85.5 million in incentives. The condition is that the company keeps at least 1,950 full-time jobs. It will not add any beyond the 600 hired this year.
China's official manufacturing index rose to 50.1 in September, back above the line after two months of contraction. Production picked up and the services and construction gauge recovered. But the index of raw material prices jumped to 60.8, the steepest reading since the spring, while the index of prices factories charge rose to 54.0. The gap between what manufacturers pay and what they get is widening again.
UBTECH opened a plant in Liuzhou on 12 September that it says will produce more than 10,000 humanoid robots a year, one every ten minutes. Some of the assembly is done by the company's own Walker S units. The interesting number is not the robots. It is the throughput.
Jaguar Land Rover confirmed the cuts on Monday. They are voluntary, they are salaried and management, and they are non-production. This paper said on Saturday that the thing to watch was which functions. That is the answer, and it is not the one the week's reporting had prepared people for.
Eurometal says 300,000 European manufacturing jobs will go before the end of this year, and marked the claim by carrying ten coffins around the European Commission. The stunt makes the figure easy to discount. The cost gap underneath it does not depend on the stunt being fair.
Jaguar Land Rover is expected to confirm 4,000 job cuts on Monday. Pre-tax profit in the last financial year came in at £14m against £2.5bn the year before, on revenue down close to 21 percent to £22.9bn. A fifth off the top line took ninety-nine percent of the profit.
Tirzepatide came off the FDA shortage list in December 2024 and semaglutide in February 2025. Ifosfamide, a decades-old chemotherapy used in curative regimens, is three months into a shortage the FDA expects to run into autumn and European regulators into 2027. Same country, same regulator, same manufacturing base.
GE Appliances is putting a billion dollars into Appliance Park in Louisville, moving dryer production from Mexico and, in an earlier tranche, washer production from China. The company says the investment secures 4,700 manufacturing jobs. The announcement was made jointly with the union.
Four years after a single plant closure emptied American shelves, formula capacity is being added. The largest project by far is Mead Johnson putting several hundred million dollars and 600,000 square feet into the plant it already owns in Zeeland, Michigan. Two much smaller lines are going into Ohio.
Ifosfamide has been in critical shortage for about three months. It is a decades-old chemotherapy used in curative and salvage regimens for sarcoma and testicular cancer, and American supply ran overwhelmingly through one contract plant in Germany, which the FDA had cited in March for recurrent microbial contamination.
America's solar manufacturing pipeline now holds 55.9GW of announced and in-build cell capacity and 41.4GW of modules. Wafers — the step that sits between polysilicon and cells, and without which neither is any use domestically — total 13.3GW across every stage of the pipeline combined.
The US Army's acquisition chief spent a day in August on a howitzer production line in Changwon. The more consequential arrangement is in Arkansas, where a Korean firm has a preliminary lease at a US arsenal to build a $1.3bn plant making nitrocellulose and nitroguanidine — the chemistry every artillery shell is built on, and the part America stopped making.
Eaton is putting $242m and 1,200 jobs into a million square feet in North Little Rock to make customised electrical enclosures, and says the plant will double its US capacity for them. A company does not double capacity for a product that is comfortably supplied.
China's factory gauge says contraction. Its high-tech sub-index says expansion. A single national figure is now averaging two manufacturing economies that are moving in opposite directions.
The Pentagon has signed seven-year framework agreements to triple Patriot interceptor output and quadruple THAAD. The dollar figure is not the interesting clause. The guaranteed minimum annual quantity is.
A would-be maker of a scarce cancer drug may produce it only while the drug is officially in shortage. Succeed at ending the shortage and the permission ends with it, which is a rule that guarantees nobody builds durable capacity.
The medicines that run short are almost never the expensive new ones. They are decades-old generics made on thin margins in a handful of plants, where a single inspection failure removes a meaningful share of world supply.
Subsidy programmes brought cell manufacturing to the continent on a schedule. The electricity those factories need arrives on a different one, set by transmission queues nobody budgeted political attention for.
Industrial equipment outlives its control software by decades. Patching it means stopping production, and the vendor that wrote it may no longer exist.
For a widening set of manufacturers, the machine is now the customer acquisition cost and the maintenance agreement is the business. The shift is rewriting how these companies are valued.
After years of supply chain speeches, the physical evidence has arrived: factory construction, border logistics investment and trade flows reorganizing around proximity.